At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

Published:2018-06-15 Issue:12 Volume:197 Page:1540-1551
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Martinez Fernando J.¹²,Han MeiLan K.²,Allinson James P.³,Barr R. Graham⁴,Boucher Richard C.⁵,Calverley Peter M. A.⁶,Celli Bartolome R.⁷,Christenson Stephanie A.⁸,Crystal Ronald G.¹,Fagerås Malin⁹,Freeman Christine M.²¹⁰,Groenke Lars¹¹,Hoffman Eric A.¹²,Kesimer Mehmet⁵,Kostikas Kostantinos¹³,Paine Robert¹⁴¹⁵,Rafii Shahin¹,Rennard Stephen I.¹¹,Segal Leopoldo N.¹⁶,Shaykhiev Renat¹,Stevenson Christopher¹⁷,Tal-Singer Ruth¹⁸,Vestbo Jørgen¹⁹,Woodruff Prescott G.⁸,Curtis Jeffrey L.²¹⁰,Wedzicha Jadwiga A.³

Affiliation:

1. Weill Cornell Medical College, New York, New York

2. University of Michigan School of Medicine, Ann Arbor, Michigan

3. Imperial College, London, United Kingdom

4. Columbia University, New York, New York

5. University of North Carolina, Chapel Hill, North Carolina

6. School of Clinical Sciences, Liverpool, United Kingdom

7. Harvard School of Medicine, Boston, Massachusetts

8. University of California at San Francisco, San Francisco, California

9. AstraZeneca Corporation, London, United Kingdom

10. Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan

11. Boehringer Ingelheim, Ingelheim, Germany

12. University of Iowa Carver College of Medicine, Iowa City, Iowa

13. Novartis Pharma, Basel, Switzerland

14. University of Utah, Salt Lake City, Utah

15. Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah

16. New York University, New York, New York

17. Janssen Pharmaceutica, Beerse, Belgium

18. GlaxoSmithKline, King of Prussia, Pennsylvania; and

19. Odense University Hospital, Odense, Denmark

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201710-2028PP

Reference133 articles.

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

2. Early chronic obstructive pulmonary disease: definition, assessment, and prevention

3. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease

4. The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development

5. Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Obstructive Pulmonary Disease;International Encyclopedia of Public Health;2025

2. Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease;Respiratory Research;2024-09-09

3. Industry 4.0-Compliant Occupational Chronic Obstructive Pulmonary Disease Prevention: Literature Review and Future Directions;Sensors;2024-09-04

4. Susceptible Young Adults and Development of Chronic Obstructive Pulmonary Disease Later in Life;American Journal of Respiratory and Critical Care Medicine;2024-09-01

5. It is high time to discard a cut-off of 0.70 in the diagnosis of COPD;Expert Review of Respiratory Medicine;2024-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3